SHC - Sotera Health Co

SHC - Sotera Health Co

https://soterahealth.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Sotera Health Announces Secondary Offering of Common Stock - Sotera Health ( NASDAQ:SHC )

Benzinga • 1 week, 4 days ago • score: 0.18

CLEVELAND, Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- Sotera Health Company SHC ( the "Company" ) today announced the launch of a secondary offering ( the "Offering" ) of 20,000,000 shares of its common stock, par value $0.01 per share.

Sotera Health Announces Secondary Offering of Common Stock

GlobeNewswire • 1 week, 4 days ago • score: 0.21

CLEVELAND, Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- Sotera Health Company ( Nasdaq: SHC ) ( the "Company" ) today announced the launch of a secondary offering ( the "Offering" ) of 20,000,000 shares of its common stock, par value $0.01 per share. All 20,000,000 shares are being offered for sale by ...

President Sterigenics Of Sotera Health Sold $2.07M In Stock - Sotera Health ( NASDAQ:SHC )

Benzinga • 2 weeks, 5 days ago • score: 0.38

Michael Rutz, President Sterigenics at Sotera Health SHC, reported an insider sell on August 26, according to a new SEC filing. What Happened: Rutz's decision to sell 126,611 shares of Sotera Health was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday.

Should You Buy Sotera Health Company ( SHC ) After Golden Cross?

Zacks Commentary • 2 weeks, 5 days ago • score: 0.41

Is it a good or bad thing when a stock experiences a golden cross technical event?

Exploring Analyst Estimates for Sotera Health ( SHC ) Q2 Earnings, Beyond Revenue and EPS

Zacks Commentary • 1 month, 1 week ago • score: 0.03

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Sotera Health (SHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical, and food industries in the Americas, Europe, and Asia. The company is headquartered in Broadview Heights, Ohio.

52W High

$17.08

52W Low

$9.53

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.84

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

173.56

Forward P/E (<15 better)

20.20

EV/EBITDA (<8 favorable)

15.55

EV/Revenue (<3 favorable)

5.74

P/S (TTM) (<3 favorable)

3.95

P/B (<3 favorable)

8.68

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

2.46%

Institutions (25–75% balanced)

96.48%

Shares Outstanding

284,047,000

Float

134,027,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

1,124,535,000

Gross Profit (TTM)

624,442,000

EPS (TTM)

0.09

Profit Margin (>10% good)

0.02%

Operating Margin (TTM) (higher better)

0.35%

ROE (TTM) (>15% strong)

0.05%

EPS YoY (Quarterly) (>10% good)

-0.07

Revenue YoY (Quarterly) (>8% good)

0.06

Momentum

Bearish momentum

Value

0.6355

Previous

0.6683

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025